Essence and consequences of enzyme induction
Induction represents an increase in activity and acceleration of the synthesis of microsomal enzymes under the action of exogenous inducers (typically lipophilic substances that act as substrates for these enzymes themselves). The process affects both phase I (non-synthetic reactions) and phase II of biotransformation (predominantly conjugation with glucuronic acid).
The main clinical consequence of induction is the accelerated degradation of medicinal substances. This leads to a drop in their blood concentration and a weakening or complete loss of therapeutic effect. A characteristic example is the reduced reliability of oral contraceptives (estrogens) when co-administered with classic inducers, creating a risk of unplanned pregnancy.
The development of the effect directly depends on the drug and takes time:
- Slow type: the classic inducer phenobarbital (Phenobarbitalum) takes weeks to unfold its effect, as the body needs time to synthesize new protein molecules.
- Fast type: rifampicin (Rifampicinum) increases enzyme activity as early as 2–4 days after starting administration.
Risks of induction: autoinduction, toxification, and carcinogenesis
Induction does not always mean a mundane decrease in drug efficacy. In a number of situations, it poses a direct threat to the patient's health:
- Toxification. If toxic compounds are formed during metabolism, their accelerated synthesis increases the risk of complications. For example, combining paracetamol with CYP2E1 inducers (chronic ethanol consumption or intake of the antituberculosis drug isoniazid / Isoniazidum) sharply increases the risk of liver damage due to the accumulation of a hepatotoxic metabolite.
- Autoinduction. A phenomenon in which a drug accelerates its own metabolism. The substance stimulates the production of enzymes that degrade it. Long-term use of barbiturates (phenobarbital) causes tolerance (tolerantia), diminishing their pharmacological effect.
- Carcinogenesis. Certain dietary and environmental components become carcinogens only after metabolic activation. The drug omeprazole (Omeprazolum), by inducing CYP1A1 and CYP1A2 isoenzymes, may increase the risk of active carcinogen formation.
Mechanisms and hazards of inhibition
During inhibition, a medicinal substance suppresses the activity of the cytochrome P-450 enzyme system. This slows down the metabolism of other drugs utilizing the same pathway. Their plasma concentrations steadily rise, leading to the risk of toxic effects (effectus toxici). Unlike induction, inhibition does not require the synthesis of new proteins and develops rapidly—the effect is registered within 24 hours.
Clinically significant interactions:
- Warfarin (anticoagulant): its oxidation via CYP3A4/3A5 is inhibited by cimetidine, macrolides, ketoconazole, or ciprofloxacin. The result is an excessive enhancement of the anticoagulant effect and the risk of bleeding (haemorrhagia).
- Cyclosporine (immunosuppressant): antifungal azoles slow down its degradation, critically increasing nephrotoxicity (nephrotoxicitas).
- Theophylline: the antibiotic ciprofloxacin blocks the CYP1A2 isoenzyme, causing a sharp increase in the toxicity of theophylline.
The prodrug paradox (Prodrugs)
A special scenario is observed when prescribing prodrugs—substances that are converted into an active metabolite only during biotransformation.
In this case, enzyme inhibition blocks drug activation, which paradoxically leads to a decrease in therapeutic effect. A striking clinical example is the co-administration of the antiplatelet agent clopidogrel and omeprazole. The antiulcer drug blocks the CYP2C19 isoenzyme (the main activation pathway for clopidogrel). As a result, the concentration of the active metabolite drops, and the patient's risk of thrombosis increases.
Influence of food, herbs, and transport proteins
Pharmacokinetics is actively altered under the influence of diet, herbal medicine, and environmental factors:
- Herbal inducers: St. John's wort (Hypericum perforatum) induces CYP3A4, weakening the action of concomitant drugs.
- Dietary inhibitors: furanocoumarins in grapefruit juice potently block CYP3A4 directly in the intestinal wall, increasing the bioavailability of many drugs and the risk of their toxicity.
- Environmental factors: polycyclic aromatic hydrocarbons from tobacco smoke and industrial pollutants (dioxins, polychlorinated biphenyls) act as potent inducers of microsomal oxidation in smokers and industrial workers.
In addition, metabolic inducers and inhibitors frequently affect transport proteins, specifically P-glycoprotein (P-glycoproteinum). This efflux ("pumping") transporter alters the absorption and distribution of substances. St. John's wort induces it, whereas grapefruit juice inhibits it.
Clinical management: any addition or withdrawal of an inducer/inhibitor requires mandatory dose adjustment of the primary drug to prevent toxicity or loss of efficacy.
Briefly: answers to topical questions
Which drugs and substances are inducers of hepatic microsomal enzymes?
Various medicinal products, food components, and environmental factors act as inducers of hepatic microsomal enzymes.
- Phenobarbital (Phenobarbitalum) is a classical slow-type inducer.
- Rifampicin (Rifampicinum) is a classical fast-type inducer.
- Isoniazid (Isoniazidum) is an antituberculosis agent.
- Omeprazole (Omeprazolum) is a pharmacological inducer of CYP1A2 and CYP1A1.
- Phenytoin and carbamazepine are antiepileptic agents.
- Macrolides and glucocorticoids are antibiotics and hormonal agents.
Inducers also include ethanol, St. John's wort herb (Hypericum perforatum), tobacco smoke, industrial pollutants (dioxins), charred food, and cruciferous vegetables.
Which drugs are inhibitors of hepatic microsomal enzymes?
Inhibitors of hepatic microsomal enzymes include drugs from various pharmacological groups that slow down the metabolism of other substances.
- Cimetidine is an H2-histamine receptor blocker.
- Macrolides (erythromycin, clarithromycin) are antibacterial agents.
- Azoles (ketoconazole, metronidazole) are antifungal drugs.
- Ciprofloxacin is an antibiotic.
- Verapamil and Diltiazem are cardiological drugs.
- Quinidine is an antiarrhythmic agent.
- Ritonavir is an antiviral agent.
- Omeprazole is a proton pump inhibitor (inhibits CYP2C19).
- Zafirlukast is a leukotriene receptor antagonist.
Which medications are prodrugs whose efficacy decreases when enzymes are inhibited?
The efficacy of prodrugs decreases during enzyme inhibition due to the blockage of their conversion into active metabolites.
- Clopidogrel is an antiplatelet agent requiring metabolic activation involving the CYP2C19 isoenzyme.
When clopidogrel is coadministered with proton pump inhibitors (e.g., omeprazole), the formation of its active metabolite is blocked. This leads to a decrease in antithrombotic activity and an increased risk of thrombosis. Other examples of prodrugs losing efficacy specifically due to enzyme inhibition are not described in the literature.
Which isoenzymes of the cytochrome P-450 system are involved in the biotransformation of drugs?
Various isoenzymes of the cytochrome P-450 system are involved in the biotransformation of drugs.
- CYP3A4 / CYP3A5 are involved in the metabolism of more than 60% of administered drugs.
- CYP2C19 is involved in the activation of clopidogrel.
- CYP2E1 is involved in the microsomal oxidation of paracetamol.
- CYP1A2 is involved in the metabolism of caffeine, theophylline, and warfarin.
- CYP1A1 is involved in the metabolic activation of carcinogens.
- CYP2D6: the metabolism of nebivolol depends on the polymorphism of this isoenzyme.
- CYP2B6 and CYP3A are involved in the oxidation of clopidogrel.
Which environmental factors and dietary components act as inducers of microsomal oxidation?
Environmental factors and dietary components acting as inducers of microsomal oxidation include:
- Tobacco smoke contains polycyclic aromatic hydrocarbons (benzopyrenes, methylcholanthrenes).
- Industrial pollutants: polychlorinated biphenyls and dioxins.
- Fried foods are associated with benzopyrenes and methylcholanthrenes.
- Cruciferous vegetables: broccoli and Brussels sprouts.
What is enzyme autoinduction, and with the intake of which drugs does it occur?
Enzyme autoinduction is the acceleration of the metabolism of the inducer itself (the drug) under the influence of increased enzyme activity. The substance stimulates the production of the enzymes that break it down, leading to a diminished pharmacological effect upon prolonged use and the development of tolerance.
Autoinduction occurs with the administration of the following drugs:
- Barbiturates (specifically, phenobarbital / Phenobarbitalum).
- Carbamazepine, an antiepileptic agent.
- Non-nucleoside reverse transcriptase inhibitors, antiviral drugs for HIV treatment.
What genetic polymorphisms of cytochrome P-450 isoenzymes exist, and how do they affect metabolic rate?
Genetic polymorphism of cytochrome P-450 isoenzymes is caused by differences in amino acid sequences, which alter enzyme activity. Based on genetic enzyme activity, the population is divided into three groups: extensive, normal, and poor metabolizers.
- CYP2C19: decreased activity leads to impaired activation of clopidogrel, while increased activity leads to excessive activation and a risk of bleeding.
- CYP2C9: for the specified therapy with *1*1, *1*2, and *2*2 genotypes, a maintenance dose of 2 mg/day is used; for *2*3 and *1*3, 1 mg/day; and for *3*3, therapy is not recommended.
- CYP2D6: in "extensive" metabolizers, the bioavailability of nebivolol is low (~12%), whereas in "poor" metabolizers, it is virtually complete (~96%); in poor metabolizers, the half-life is prolonged to 30–50 hours, and the cardioselectivity of the drug is significantly lower.
How does patient age affect the activity of hepatic microsomal enzymes?
In elderly and senile age, biotransformation of drugs slows down. This is due to a decrease in hepatic enzyme activity as well as reduced hepatic blood flow. As a result, drug metabolism slows down, requiring dosage adjustments. For patients over 60 years of age, potent and toxic drugs are prescribed at 2/3 of the standard dose for middle-aged adults.
The reverse rule applies to prodrugs: inhibition = decreased effect (no metabolism = no active substance).
Class and exam questions
Why does inhibition occur faster than induction?
Inhibition merely blocks the action of existing enzyme molecules, so the effect is noticeable within 24 hours. Induction requires de novo synthesis of new proteins, which takes anywhere from a few days (rifampicin) to weeks (phenobarbital).
Can enzyme induction lead to drug poisoning?
Yes, this phenomenon is called toxification. If metabolism produces compounds that are more toxic than the parent substance, induction will accelerate their accumulation (for example, during paracetamol metabolism against the background of chronic alcohol intake).
Why is grapefruit juice often contraindicated with medications?
Grapefruit juice contains furanocoumarins, which inhibit the CYP3A4 isoenzyme in the intestinal wall and block P-glycoprotein. This drastically increases drug bioavailability and the risk of dangerous toxic effects.
What else to study on this topic
- Mechanisms of tolerance development during the autoinduction phenomenon (using barbiturates as an example)
- Bioactivation of carcinogens via CYP1A1 and CYP1A2 isoenzymes
- The role of P-glycoprotein (P-glycoproteinum) in drug efflux
- The effect of tobacco smoke and polycyclic aromatic hydrocarbons on pharmacokinetics
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Enzyme Induction and Inhibition" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in "General Pharmacology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.